Back to CRVS
ORBIMED ADVISORS LLC CRVS Position History
Corvus Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$82.5M
Q3 2026
Peak value
$107M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $55.2M |
| Q1 2026 | $104.8M |
| Q2 2026 | $107M |
| Q3 2026 | $82.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $82.5M | 7.17M | — | — |
| Q2 2026 | $107M | 7.17M | — | — |
| Q1 2026 | $104.8M | 7.17M | — | — |
| Q4 2025 | $55.2M | 7.17M | — | — |